L01E Protein kinase inhibitors Protein kinase inhibitors Protein kinase inhibitors Protein kinase inhibitors L3
Source: Wikipedia · CC BY-SA 4.0 Fuente: Wikipedia · CC BY-SA 4.0 · nombre de respaldo (en) 来源:维基百科 · CC BY-SA 4.0 · 回退名 (en) 來源:維基百科 · CC BY-SA 4.0 · 回退名 (en)
ATC level L3 · Search this class · Consumer categories
Child classes
L01EABCR-ABL tyrosine kinase inhibitors BCR-ABL tyrosine kinase inhibitors BCR-ABL tyrosine kinase inhibitors BCR-ABL tyrosine kinase inhibitorsL01EBEpidermal growth factor receptor (EGFR) tyrosine kinase inhibitors Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitorsL01ECB-Raf serine-threonine kinase (BRAF) inhibitors B-Raf serine-threonine kinase (BRAF) inhibitors B-Raf serine-threonine kinase (BRAF) inhibitors B-Raf serine-threonine kinase (BRAF) inhibitorsL01EDAnaplastic lymphoma kinase (ALK) inhibitors Anaplastic lymphoma kinase (ALK) inhibitors Anaplastic lymphoma kinase (ALK) inhibitors Anaplastic lymphoma kinase (ALK) inhibitorsL01EEMitogen-activated protein kinase (MEK) inhibitors Mitogen-activated protein kinase (MEK) inhibitors Mitogen-activated protein kinase (MEK) inhibitors Mitogen-activated protein kinase (MEK) inhibitorsL01EFCyclin-dependent kinase (CDK) inhibitors Cyclin-dependent kinase (CDK) inhibitors Cyclin-dependent kinase (CDK) inhibitors Cyclin-dependent kinase (CDK) inhibitorsL01EGMammalian target of rapamycin (mTOR) kinase inhibitors Mammalian target of rapamycin (mTOR) kinase inhibitors Mammalian target of rapamycin (mTOR) kinase inhibitors Mammalian target of rapamycin (mTOR) kinase inhibitorsL01EHHuman epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitorsL01EJJanus-associated kinase (JAK) inhibitors Janus-associated kinase (JAK) inhibitors Janus-associated kinase (JAK) inhibitors Janus-associated kinase (JAK) inhibitorsL01EKVascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitorsL01ELBruton's tyrosine kinase (BTK) inhibitors Bruton's tyrosine kinase (BTK) inhibitors Bruton's tyrosine kinase (BTK) inhibitors Bruton's tyrosine kinase (BTK) inhibitorsL01EMPhosphatidylinositol-3-kinase (Pi3K) inhibitors Phosphatidylinositol-3-kinase (Pi3K) inhibitors Phosphatidylinositol-3-kinase (Pi3K) inhibitors Phosphatidylinositol-3-kinase (Pi3K) inhibitorsL01ENFibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitorsL01EPCellular-mesenchymal-epithelial transition factor (c-MET) kinase inhibitors Cellular-mesenchymal-epithelial transition factor (c-MET) kinase inhibitors Cellular-mesenchymal-epithelial transition factor (c-MET) kinase inhibitors Cellular-mesenchymal-epithelial transition factor (c-MET) kinase inhibitorsL01EXOther protein kinase inhibitors Other protein kinase inhibitors Other protein kinase inhibitors Other protein kinase inhibitors
Active ingredients in this class
132 active ingredients 132 principios activos 132 个活性成分 132 個有效成分
Each market now shows one aggregated status: a market counts as on sale if it has any active record; individual record statuses are shown in the details. The same market can also have several registration records with different statuses, so each market appears only once here; that is a record fact, not a safety judgement.
A missing name is marked in its row only when it is the exception; when most names lack it, the list stays unmarked.
- Dasatinib
L01EA02active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG CN ES MX TW EU · unknown HK - Imatinib
L01EA01active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG CN ES MX TW EU · unknown HK - Everolimus
L01EG02active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG CN ES MX TW EU · unknown HK - Erlotinib
L01EB02active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG CN ES MX TW EU · unknown HK - Gefitinib
L01EB01active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG CN ES MX TW EU · unknown HK - Lenvatinib
L01EX08active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG CN ES MX TW EU · unknown HK - Sorafenib
L01EX02active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG CN ES MX TW EU · unknown HK - Axitinib
L01EK01active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG CN ES MX TW EU · unknown HK - Ibrutinib
L01EL01active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG CN ES MX TW EU · unknown HK - Osimertinib
L01EB04active US GB CA AU SG · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA AU SG CN ES TW EU · discontinued MX · unknown HK - Fruquintinib
L01EK04active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG CN ES MX TW EU · unknown HK - Alectinib
L01ED03active US GB CA AU SG · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA AU SG CN ES TW EU · discontinued MX · unknown HK - Sunitinib
L01EX01Salt form: Sunitinib Malate
Sunitinib Malateactive US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG ES MX TW EU · unknown HK - Nilotinib
L01EA03active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG CN ES EU · unknown MX HK - Palbociclib
L01EF01active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG ES MX TW EU · unknown HK - Pazopanib
L01EX03active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG ES MX TW EU · unknown HK - Brigatinib
L01ED04active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG CN ES TW EU · unknown HK - Abemaciclib
L01EF03active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG ES TW EU · discontinued MX · unknown HK - Alpelisib
L01EM03active US GB CA SG ES · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA SG ES MX TW EU · unknown AU HK - Dabrafenib
L01EC02active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG CN ES TW EU · unknown HK - Crizotinib
L01ED01active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG CN ES TW EU · unknown HK - Entrectinib
L01EX14active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG CN ES TW EU · unknown HK - Regorafenib
L01EX05active US GB CA SG CN · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA SG CN ES TW EU · unknown AU HK - Capivasertib
L01EX27active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG MX TW EU · discontinued ES · unknown HK - Lazertinib
L01EB09active US GB CA SG ES · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA SG ES MX TW EU · unknown AU HK - Zanubrutinib
L01EL03active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG CN ES TW EU · unknown HK - Encorafenib
L01EC03active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG ES MX TW EU · unknown HK - Ribociclib
L01EF02active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG ES TW EU · discontinued MX · unknown HK - Tucatinib
L01EH03active US GB CA SG ES · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA SG ES MX TW EU · unknown AU HK - Gilteritinib
L01EX13Salt form: Gilteritinib Fumarate
Gilteritinib Fumarateactive US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG CN ES TW EU · unknown HK - Ripretinib
L01EX19active US GB CA AU SG · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU SG CN ES TW EU · unknown HK - Neratinib
L01EH02Salt form: Neratinib Maleate
Neratinib Maleateactive US GB CA SG ES · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA SG ES MX TW EU · unknown AU HK - Ruxolitinib
L01EJ01active US GB CA AU SG · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA AU SG ES TW EU · unknown HK - Cabozantinib
L01EX07Salt form: Cabozantinib-Malate
Cabozantinib-Malateactive GB CA AU SG ES · and 6 more y 6 más 另有 6 个 另有 6 個
active GB CA AU SG ES TW EU · discontinued MX · unknown HK - Selpercatinib
L01EX22active US GB CA AU SG · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA AU SG ES TW EU · unknown HK - Larotrectinib
L01EX12Salt form: Larotrectinib Sulfate
Larotrectinib Sulfateactive US GB CA AU SG · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA AU SG ES TW EU · unknown HK - Asciminib
L01EA06Salt form: Asciminib Hydrochloride
Asciminib Hydrochlorideactive US GB CA AU SG · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA AU SG ES TW EU · unknown HK - Pemigatinib
L01EN02active US GB CA SG ES · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA SG ES TW EU · unknown AU HK - Ponatinib
L01EA05active US GB CA AU SG · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA AU SG CN ES EU · unknown HK - Erdafitinib
L01EN01active US GB CA SG ES · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA SG ES MX TW EU · unknown HK - Acalabrutinib
L01EL02Salt form: Acalabrutinib Maleate Monohydrate
Acalabrutinib Maleate Monohydrateactive US GB CA AU SG · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA AU SG ES TW EU · unknown HK - Dacomitinib
L01EB07active US GB SG ES MX · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB SG ES MX TW EU · discontinued CA · unknown HK - Lorlatinib
L01ED05active US GB CA AU SG · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA AU SG ES TW EU · unknown HK - Midostaurin
L01EX10active US GB CA AU SG · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA AU SG ES TW EU · unknown HK - Inavolisib
L01EM06active US GB CA SG ES · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA SG ES TW EU · unknown AU HK - Binimetinib
L01EE03active US GB CA AU SG · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA AU SG ES TW EU · unknown HK - Vemurafenib
L01EC01active US GB CA AU SG · and 4 more y 4 más 另有 4 个 另有 4 個
active US GB CA AU SG CN ES TW EU - Tepotinib
L01EP02L01EX21Salt form: Tepotinib Hydrochloride Monohydrate
Tepotinib Hydrochloride Monohydrateactive US GB CA AU SG · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA AU SG ES TW EU · unknown HK - Afatinib
L01EB03active US GB AU CN ES · and 4 more y 4 más 另有 4 个 另有 4 個
active US GB AU CN ES EU · unknown MX HK - Bosutinib
L01EA04active US GB CA ES MX · and 4 more y 4 más 另有 4 个 另有 4 個
active US GB CA ES MX TW EU · unknown AU - Trametinib
L01EE01active GB CA AU SG CN · and 4 more y 4 más 另有 4 个 另有 4 個
active GB CA AU SG CN ES EU · unknown HK - Momelotinib
L01EJ04active US GB CA AU SG · and 4 more y 4 más 另有 4 个 另有 4 個
active US GB CA AU SG ES EU · unknown HK - Selumetinib
L01EE04Salt form: Selumetinib Sulfate
Selumetinib Sulfateactive US GB CA AU SG · and 4 more y 4 más 另有 4 个 另有 4 個
active US GB CA AU SG ES EU · unknown HK - Capmatinib
L01EP01active US CA SG ES TW · and 4 more y 4 más 另有 4 个 另有 4 個
active US CA SG ES TW EU · unknown AU HK - Pirtobrutinib
L01EL05active US GB CA ES TW · and 4 more y 4 más 另有 4 个 另有 4 個
active US GB CA ES TW EU · unknown AU HK - Vandetanib
L01EX04active US GB CA ES TW · and 4 more y 4 más 另有 4 个 另有 4 個
active US GB CA ES TW EU · unknown AU HK - Ceritinib
L01ED02active US GB CA AU SG · and 3 more y 3 más 另有 3 个 另有 3 個
active US GB CA AU SG ES TW EU - Cobimetinib
L01EE02active US GB CA AU SG · and 3 more y 3 más 另有 3 个 另有 3 個
active US GB CA AU SG ES TW EU - Fedratinib
L01EJ02Salt form: Fedratinib Hydrochloride
Fedratinib Hydrochlorideactive US GB CA AU SG · and 3 more y 3 más 另有 3 个 另有 3 個
active US GB CA AU SG ES TW EU - Nintedanib
L01EX09active GB AU SG ES MX · and 3 more y 3 más 另有 3 个 另有 3 個
active GB AU SG ES MX EU · unknown HK - Avapritinib
L01EX18active US GB CA ES TW · and 3 more y 3 más 另有 3 个 另有 3 個
active US GB CA ES TW EU · unknown HK - Quizartinib
L01EX11active US GB CA ES TW · and 3 more y 3 más 另有 3 个 另有 3 個
active US GB CA ES TW EU · unknown HK - Lapatinib
L01EH01active GB AU CN ES EU · and 3 more y 3 más 另有 3 个 另有 3 個
active GB AU CN ES EU · unknown MX HK - Futibatinib
L01EN04active US GB AU SG ES · and 3 more y 3 más 另有 3 个 另有 3 個
active US GB AU SG ES EU · unknown HK - Pralsetinib
L01EX23active US GB TW · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB TW · discontinued CA · withdrawn ES EU · unknown HK - Idelalisib
L01EM01active US GB CA AU ES · and 1 more y 1 más 另有 1 个 另有 1 個
active US GB CA AU ES EU - Repotrectinib
L01EX28active US AU TW EU · and 4 more y 4 más 另有 4 个 另有 4 個
active US AU TW EU · discontinued CA · unknown HK - Afatinib Dimaleate
L01EB03active US CA SG TW · and 2 more y 2 más 另有 2 个 另有 2 個
active US CA SG TW · unknown AU - Lapatinib Ditosylate
L01EH01active US CA SG TW · and 2 more y 2 más 另有 2 个 另有 2 個
active US CA SG TW · unknown AU - Temsirolimus
L01EG01active GB CA ES EU · and 2 more y 2 más 另有 2 个 另有 2 個
active GB CA ES EU · unknown MX - Tivozanib
L01EK03active US GB ES EU
active US GB ES EU - Sevabertinib
L01EH06active US GB CA TW
active US GB CA TW - Mirdametinib
L01EE05active US EU · and 2 more y 2 más 另有 2 个 另有 2 個
active US EU · discontinued ES - Vimseltinib
L01EX29active US EU · and 2 more y 2 más 另有 2 个 另有 2 個
active US EU · discontinued ES - Tovorafenib
L01EC04active US CA EU
active US CA EU - Zongertinib
L01EH04active US CA · and 2 more y 2 más 另有 2 个 另有 2 個
active US CA · unknown HK - Nintedanib Esilate
L01EX09active CA · and 2 more y 2 más 另有 2 个 另有 2 個
active CA · unknown AU - Infigratinib
L01EN03discontinued CA · and 2 more y 2 más 另有 2 个 另有 2 個
discontinued CA · unknown AU - Duvelisib
L01EM04active US · and 2 more y 2 más 另有 2 个 另有 2 個
active US · withdrawn EU - Mobocertinib
L01EB10active GB · and 2 more y 2 más 另有 2 个 另有 2 個
active GB · withdrawn EU
Show all 132 (currently showing 80) Mostrar los 132 (ahora se muestran 80) 显示全部 132 个(当前显示前 80 个) 顯示全部 132 個(目前顯示前 80 個)
- Pexidartinib
L01EX15active US · and 2 more y 2 más 另有 2 个 另有 2 個
active US · unknown EU - 哌柏西利
L01EFactive CN
active CN - 乙磺酸尼达尼布
L01EXactive CN
active CN - Anlotinib
L01EKactive CN
active CN - 苹果酸舒尼替尼
L01EXactive CN
active CN - 培唑帕尼
L01EXactive CN
active CN - 富马酸安奈克替尼
L01EXactive CN
active CN - 塞普替尼
L01EXactive CN
active CN - 洛拉替尼
L01EDactive CN
active CN - 甲磺酸阿帕替尼
L01EKactive CN
active CN - 羟乙磺酸达尔西利
L01EFactive CN
active CN - 马来酸奈拉替尼
L01EHactive CN
active CN - 伯瑞替尼
L01EXactive CN
active CN - 甲磺酸阿美替尼
L01EBactive CN
active CN - 盐酸卡马替尼
L01EXactive CN
active CN - 伊鲁阿克
L01EDactive CN
active CN - 阿伐替尼
L01EXactive CN
active CN - 甲磺酸氟马替尼
L01EAactive CN
active CN - 硫酸拉罗替尼
L01EXactive CN
active CN - 普拉替尼
L01EXactive CN
active CN - 琥珀酸瑞波西利
L01EFactive CN
active CN - 马来酸吡咯替尼
L01EHactive CN
active CN - 枸橼酸依奉阿克
L01EDactive CN
active CN - 甲苯磺酸多纳非尼
L01EXactive CN
active CN - 佩米替尼
L01ENactive CN
active CN - 舒沃替尼
L01EBactive CN
active CN - 甲磺酸贝福替尼
L01EBactive CN
active CN - 硫酸艾玛昔替尼
L01EJactive CN
active CN - 盐酸特泊替尼
L01EXactive CN
active CN - 甲磺酸瑞厄替尼
L01EBactive CN
active CN - 度维利塞
L01EMactive CN
active CN - 赛沃替尼
L01EXactive CN
active CN - 盐酸佐利替尼
L01EBactive CN
active CN - 硫酸氢司美替尼
L01EEactive CN
active CN - 利厄替尼
L01EBactive CN
active CN - 伊那利塞
L01EMactive CN
active CN - 妥拉美替尼
L01EEactive CN
active CN - 瑞派替尼
L01EXactive CN
active CN - 己二酸他雷替尼
L01EXactive CN
active CN - 林普利塞
L01EMactive CN
active CN - 伏罗尼布
L01EKactive CN
active CN - 索凡替尼
L01EKactive CN
active CN - 维迪西妥单抗
L01EHactive CN
active CN - 氟泽雷塞
L01EXactive CN
active CN - 甲磺酸瑞齐替尼
L01EBactive CN
active CN - 马来酸阿可替尼
L01ELactive CN
active CN - 戈利昔替尼
L01EJactive CN
active CN - 匹妥布替尼
L01ELactive CN
active CN - 阿可替尼
L01ELactive CN
active CN - 谷美替尼
L01EXactive CN
active CN - Pacritinib
L01EJ03active US
active US - 琥珀酸莫博赛替尼
L01EB
Class names are editorial translations or come from Wikipedia (CC BY-SA 4.0) / Wikidata (CC0); each ATC page lists the exact source, licence and link for every language. Only the ATC code and the WHO hierarchy are authoritative.
Notes & licences
Status badges summarise the product records held for each ingredient (active / discontinued / withdrawn / unknown), and the market codes after each badge show where that status is recorded. Only some registers publish a status column: CA, ES and MX do; AU and HK have no status column and are recorded as unknown; CN, US, GB, TW and SG records are on the register and marked active.
Class and category names are editorial or AI-assisted translations; only the ATC code and the WHO hierarchy are authoritative.
ATC codes and hierarchy reference the WHO Collaborating Centre for Drug Statistics Methodology ATC/DDD Index (copyright WHOCC; the index itself is not reproduced). Ingredient/strength facts come from the regulator records listed on About.